By Professor Glenda Halliday

Journal articles

Orme T; Hernandez D; Ross OA; Kun-Rodrigues C; Darwent L; Shepherd CE; Parkkinen L; Ansorge O; Clark L; Honig LS; Marder K; Lemstra A; Rogaeva E; St. George-Hyslop P; Londos E; Zetterberg H; Morgan K; Troakes C; Al-Sarraj S; Lashley T; Holton J; Compta Y; Van Deerlin V; Trojanowski JQ; Serrano GE; Beach TG; Lesage S; Galasko D; Masliah E; Santana I; Pastor P; Tienari PJ; Myllykangas L; Oinas M; Revesz T; Lees A; Boeve BF; Petersen RC; Ferman TJ; Escott-Price V; Graff-Radford N; Cairns NJ; Morris JC; Pickering-Brown S; Mann D; Halliday G; Stone DJ; Dickson DW; Hardy J; Singleton A; Guerreiro R; Bras J, 2020, 'Analysis of neurodegenerative disease-causing genes in dementia with Lewy bodies', Acta Neuropathologica Communications, 8, http://dx.doi.org/10.1186/s40478-020-0879-z

Carter A; Richards LJ; Apthorp D; Azghadi MR; Badcock DR; Balleine B; Bekkers JM; Berk M; Bourne JA; Bradley AP; Breakspear M; Brichta A; Carter O; Castles A; Chakli K; Cohen-Woods S; Conn SJ; Cornish J; Cornish K; de Zubicaray G; Egan GF; Enticott PG; Fitzgibbon BM; Forlini C; Fornito A; Griffiths L; Gullifer J; Hall W; Halliday G; Hannan AJ; Harrer S; Harvey A; Hatherly C; Hickie IB; Kennett J; Kiernan M; Kilpatrick T; Kiral-Kornek I; Korgaonkar MS; Lawrence AJ; Leventer R; Levy N; Licinio J; Lovell N; Mackellar G; Malcolm L; Mason A; Mattingley JB; Medland SE; Michie PT; Nithianantharajah J; Parker J; Payne JM; Poole-Warren L; Sah P; Sarnyai Z; Schofield PR; Shimoni O; Shum DHK; Silk T; Slee M; Smith AE; Soulis T; Sriram S; Stuart GJ; Tapson J; Thompson MB; van Schaik A; Vincent NA; Vissel B; Waters A, 2020, 'Erratum: A Neuroethics Framework for the Australian Brain Initiative (Neuron (2019) 101(3) (365–369), (S0896627319300054), (10.1016/j.neuron.2019.01.004))', Neuron, 105, pp. 201, http://dx.doi.org/10.1016/j.neuron.2019.12.019

Szeto JYY; Walton CC; Rizos A; Martinez-Martin P; Halliday GM; Naismith SL; Chaudhuri KR; Lewis SJG, 2020, 'Dementia in long-term Parkinson's disease patients: a multicentre retrospective study.', NPJ Parkinsons Dis, 6, pp. 2, http://dx.doi.org/10.1038/s41531-019-0106-4

Forrest SL; Halliday GM; Sizemova A; van Roijen M; McGinley CV; Bright F; Kapur M; McGeachie AB; McCann H; Shepherd CE; Tan RH; Affleck AJ; Huang Y; Kril JJ, 2020, 'A practical approach to differentiate the frontotemporal tauopathy subtypes', Journal of Neuropathology and Experimental Neurology, 79, pp. 1122 - 1126, http://dx.doi.org/10.1093/jnen/nlaa100

Affleck AJ; Sachdev PS; Stevens J; Halliday GM, 2020, 'Antihypertensive medications ameliorate Alzheimer's disease pathology by slowing its propagation', Alzheimer's and Dementia: Translational Research and Clinical Interventions, 6, http://dx.doi.org/10.1002/trc2.12060

Ehgoetz Martens KA; Matar E; Hall JM; Phillips J; Szeto JYY; Gouelle A; Grunstein RR; Halliday GM; Lewis SJG, 2020, 'Invited Reply to: “Instrumental Analysis of Gait Abnormalities in Idiopathic Rapid Eye Movement Sleep Behavior Disorder”', Movement Disorders, 35, pp. 195 - 196, http://dx.doi.org/10.1002/mds.27939

Amadoru S; Doré V; McLean C; Hinton F; Shepherd C; Halliday G; Leyton C; Yates P; Hodges J; Masters C; Villemagne V; Rowe C, 2020, 'Comparison of amyloid PET measured in Centiloid units with neuropathological findings in Alzheimer’s Disease', , http://dx.doi.org/10.21203/rs.2.17082/v2

Bechara JA; Brooks WS; Kwok JB; Halliday GM; Schofield PR, 2020, 'Familial Alzheimer’s disease in Australia', Alzheimer's & Dementia, 16, http://dx.doi.org/10.1002/alz.040062

Roudeau S; Trist B; Carmona A; Davies K; M. Halliday G; Rufin Y; Claverol S; Van Malderen SJM; Falkenberg G; Double K; Ortega R, 2020, 'Native Separation and Metallation Analysis of SOD1 Protein from the Human Central Nervous System: A Methodological Workflow', , http://dx.doi.org/10.26434/chemrxiv.13415918.v1

Pires G; McElligott S; Drusinsky S; Halliday G; Potier MC; Wisniewski T; Drummond E, 2019, 'Secernin-1 is a novel phosphorylated tau binding protein that accumulates in Alzheimer's disease and not in other tauopathies', Acta Neuropathologica Communications, 7, http://dx.doi.org/10.1186/s40478-019-0848-6

Bonham LW; Steele NZR; Karch CM; Broce I; Geier EG; Wen NL; Momeni P; Hardy J; Miller ZA; Gorno-Tempini ML; Hess CP; Lewis P; Miller BL; Seeley WW; Manzoni C; Desikan RS; Baranzini SE; Ferrari R; Yokoyama JS; Hernandez DG; Nalls MA; Rohrer JD; Ramasamy A; Kwok JBJ; Dobson-Stone C; Schofield PR; Halliday GM; Hodges JR; Piguet O; Bartley L; Thompson E; Haan E; Hernández I; Ruiz A; Boada M; Borroni B; Padovani A; Cruchaga C; Cairns NJ; Benussi L; Binetti G; Ghidoni R; Forloni G; Albani D; Galimberti D; Fenoglio C; Serpente M; Scarpini E; Clarimón J; Lleó A; Blesa R; Landqvist Waldö M; Nilsson K; Nilsson C; Mackenzie IRA; Hsiung GYR; Mann DMA; Grafman J; Morris CM; Attems J; Griffiths TD; McKeith IG; Thomas AJ; Pietrini P; Huey ED; Wassermann EM; Baborie A; Jaros E; Tierney MC; Pastor P; Razquin C; Ortega-Cubero S; Alonso E; Perneczky R; Diehl-Schmid J; Alexopoulos P; Kurz A; Rainero I; Rubino E; Pinessi L; Rogaeva E; St George-Hyslop P; Rossi G; Tagliavini F; Giaccone G; Rowe JB; Schlachetzki JCM; Uphill J; Collinge J; Mead S; Danek A; Van Deerlin VM; Grossman M; Trojanowski JQ; van der Zee J; Cruts M; Van Broeckhoven C; Cappa SF; Leber I; Hannequin D, 2019, 'Genetic variation across RNA metabolism and cell death gene networks is implicated in the semantic variant of primary progressive aphasia', Scientific Reports, 9, http://dx.doi.org/10.1038/s41598-019-46415-1

Forrest SL; Halliday GM; McCann H; McGeachie AB; McGinley CV; Hodges JR; Piguet O; Kwok JB; Spillantini MG; Kril JJ, 2019, 'Heritability in frontotemporal tauopathies', Alzheimer's and Dementia: Diagnosis, Assessment and Disease Monitoring, 11, pp. 115 - 124, http://dx.doi.org/10.1016/j.dadm.2018.12.001

Nalls MA; Blauwendraat C; Vallerga CL; Heilbron K; Bandres-Ciga S; Chang D; Tan M; Kia DA; Noyce AJ; Xue A; Bras J; Young E; von Coelln R; Simón-Sánchez J; Schulte C; Sharma M; Krohn L; Pihlstrøm L; Siitonen A; Iwaki H; Leonard H; Faghri F; Gibbs JR; Hernandez DG; Scholz SW; Botia JA; Martinez M; Corvol JC; Lesage S; Jankovic J; Shulman LM; Sutherland M; Tienari P; Majamaa K; Toft M; Andreassen OA; Bangale T; Brice A; Yang J; Gan-Or Z; Gasser T; Heutink P; Shulman JM; Wood NW; Hinds DA; Hardy JA; Morris HR; Gratten J; Visscher PM; Graham RR; Singleton AB; Adarmes-Gómez AD; Aguilar M; Aitkulova A; Akhmetzhanov V; Alcalay RN; Alvarez I; Alvarez V; Barrero FJ; Bergareche Yarza JA; Bernal-Bernal I; Billingsley K; Blazquez M; Bonilla-Toribio M; Boungiorno MT; Brockmann K; Bubb V; Buiza-Rueda D; Cámara A; Carrillo F; Carrión-Claro M; Cerdan D; Chelban V; Clarimón J; Clarke C; Compta Y; Cookson MR; Craig DW; Danjou F; Diez-Fairen M; Dols-Icardo O; Duarte J; Duran R; Escamilla-Sevilla F; Escott-Price V; Ezquerra M; Feliz C; Fernández M; Fernández-Santiago R; Finkbeiner S; Foltynie T; Garcia C; García-Ruiz P; Gomez Heredia MJ; Gómez-Garre P; González MM; Gonzalez-Aramburu I; Guelfi S; Guerreiro R, 2019, 'Identification of novel risk loci, causal insights, and heritable risk for Parkinson's disease: a meta-analysis of genome-wide association studies', The Lancet Neurology, 18, pp. 1091 - 1102, http://dx.doi.org/10.1016/S1474-4422(19)30320-5

Reynolds RH; Botía J; Nalls MA; Noyce AJ; Nicolas A; Cookson MR; Bandres-Ciga S; Gibbs JR; Hernandez DG; Singleton AB; Reed X; Leonard H; Blauwendraat C; Faghri F; Bras J; Guerreiro R; Tucci A; Kia DA; Houlden H; Plun-Favreau H; Mok KY; Wood NW; Lovering R; R’Bibo L; Rizig M; Chelban V; Trabzuni D; Tan M; Morris HR; Middlehurst B; Quinn J; Billingsley K; Holmans P; Kinghorn KJ; Lewis P; Escott-Price V; Williams N; Foltynie T; Brice A; Danjou F; Lesage S; Corvol JC; Martinez M; Giri A; Schulte C; Brockmann K; Simón-Sánchez J; Heutink P; Gasser T; Rizzu P; Sharma M; Shulman JM; Robak L; Lubbe S; Mencacci NE; Finkbeiner S; Lungu C; Scholz SW; Gan-Or Z; Rouleau GA; Krohan L; van Hilten JJ; Marinus J; Adarmes-Gómez AD; Bernal-Bernal I; Bonilla-Toribio M; Buiza-Rueda D; Carrillo F; Carrión-Claro M; Mir P; Gómez-Garre P; Jesús S; Labrador-Espinosa MA; Macias D; Vargas-González L; Méndez-del-Barrio C; Periñán-Tocino T; Tejera-Parrado C; Diez-Fairen M; Aguilar M; Alvarez I; Boungiorno MT; Carcel M; Pastor P; Tartari JP; Alvarez V; González MM; Blazquez M; Garcia C; Suarez-Sanmartin E; Barrero FJ; Rezola EM; Yarza JAB; Pagola AG; de Munain Arregui AL; Ruiz-Martínez J; Cerdan D; Duarte J; Clarimón J; Dols-Icardo O, 2019, 'Moving beyond neurons: the role of cell type-specific gene regulation in Parkinson’s disease heritability', npj Parkinson's Disease, 5, http://dx.doi.org/10.1038/s41531-019-0076-6

Ahmadi Rastegar D; Ho N; Halliday GM; Dzamko N, 2019, 'Parkinson’s progression prediction using machine learning and serum cytokines', npj Parkinson's Disease, 5, http://dx.doi.org/10.1038/s41531-019-0086-4

Strohäker T; Jung BC; Liou SH; Fernandez CO; Riedel D; Becker S; Halliday GM; Bennati M; Kim WS; Lee SJ; Zweckstetter M, 2019, 'Structural heterogeneity of α-synuclein fibrils amplified from patient brain extracts', Nature Communications, 10, http://dx.doi.org/10.1038/s41467-019-13564-w

McCann EP; Fifita JA; Grima N; Galper J; Mehta P; Freckleton SE; Zhang KY; Henden L; Hogan AL; Fat SCM; Wu SSL; Jagaraj CJ; Berning BA; Williams KL; Twine NA; Bauer D; Piguet O; Hodges J; Kwok JBJ; Halliday GM; Kiernan MC; Atkin J; Rowe DB; Nicholson GA; Walker AK; Blair IP; Yang S, 2019, 'Genetic and immunopathological analysis of CHCHD10 in Australian amyotrophic lateral sclerosis and frontotemporal dementia and transgenic TDP-43 mice', Journal of Neurology, Neurosurgery and Psychiatry, 91, pp. 162 - 171, http://dx.doi.org/10.1136/jnnp-2019-321790

Yang Y; Halliday GM; Kiernan MC; Tan RH, 2019, 'TDP-43 levels in the brain tissue of ALS cases with and without C9ORF72 or ATXN2 gene expansions', Neurology, 93, pp. e1748 - e1755, http://dx.doi.org/10.1212/WNL.0000000000008439

Forrest SL; Kril JJ; Halliday GM, 2019, 'Cellular and regional vulnerability in frontotemporal tauopathies', Acta Neuropathologica, 138, pp. 705 - 727, http://dx.doi.org/10.1007/s00401-019-02035-7

Virachit S; Mathews KJ; Cottam V; Werry E; Galli E; Rappou E; Lindholm P; Saarma M; Halliday GM; Shannon Weickert C; Double KL, 2019, 'Levels of glial cell line-derived neurotrophic factor are decreased, but fibroblast growth factor 2 and cerebral dopamine neurotrophic factor are increased in the hippocampus in Parkinson’s disease', Brain Pathology, 29, pp. 813 - 825, http://dx.doi.org/10.1111/bpa.12730

Hsiao JHT; Purushothuman S; Jensen PH; Halliday GM; Kim WS, 2019, 'Reductions in COQ2 Expression Relate to Reduced ATP Levels in Multiple System Atrophy Brain', Frontiers in Neuroscience, 13, http://dx.doi.org/10.3389/fnins.2019.01187

Matar E; Shine JM; Halliday GM; Lewis SJG, 2019, 'Cognitive fluctuations in Lewy body dementia: towards a pathophysiological framework', Brain, http://dx.doi.org/10.1093/brain/awz311

Leak RK; Frosch MP; Beach TG; Halliday GM, 2019, 'Alpha-synuclein: prion or prion-like?', Acta Neuropathologica, 138, pp. 509 - 514, http://dx.doi.org/10.1007/s00401-019-02057-1

Shehadeh J; Double KL; Murphy KE; Bobrovskaya L; Reyes S; Dunkley PR; Halliday GM; Dickson PW, 2019, 'Expression of tyrosine hydroxylase isoforms and phosphorylation at serine 40 in the human nigrostriatal system in Parkinson's disease', Neurobiology of Disease, 130, http://dx.doi.org/10.1016/j.nbd.2019.104524

Gao J; Perera G; Bhadbhade M; Halliday GM; Dzamko N, 2019, 'Autophagy activation promotes clearance of α-synuclein inclusions in fibril-seeded human neural cells', Journal of Biological Chemistry, 294, pp. 14241 - 14256, http://dx.doi.org/10.1074/jbc.RA119.008733

Ke YD; Chan G; Stefanoska K; Au C; Bi M; Müller J; Przybyla M; Feiten A; Prikas E; Halliday GM; Piguet O; Kiernan MC; Kassiou M; Hodges JR; Loy CT; Mattick JS; Ittner A; Kril JJ; Sutherland GT; Ittner LM, 2019, 'CNS cell type-specific gene profiling of P301S tau transgenic mice identifies genes dysregulated by progressive tau accumulation', Journal of Biological Chemistry, 294, pp. 14149 - 14162, http://dx.doi.org/10.1074/jbc.RA118.005263

Lee JS; Kanai K; Suzuki M; Kim WS; Yoo HS; Fu YH; Kim DK; Jung BC; Choi M; Oh KW; Li Y; Nakatani M; Nakazato T; Sekimoto S; Funayama M; Yoshino H; Kubo SI; Nishioka K; Sakai R; Ueyama M; Mochizuki H; Lee HJ; Sardi SP; Halliday GM; Nagai Y; Lee PH; Hattori N; Lee SJ, 2019, 'Arylsulfatase A, a genetic modifier of Parkinson’s disease, is an α-synuclein chaperone', Brain, 142, pp. 2845 - 2859, http://dx.doi.org/10.1093/brain/awz205

Matar E; Phillips JR; Martens KAE; Halliday GM; Lewis SJG, 2019, 'Impaired Color Discrimination—A Specific Marker of Hallucinations in Lewy Body Disorders', Journal of Geriatric Psychiatry and Neurology, 32, pp. 257 - 264, http://dx.doi.org/10.1177/0891988719845501

Shepherd CE; McGeachie AB; Affleck AJ; Halliday GM, 2019, 'Letter to the editor', Journal of Neuropathology and Experimental Neurology, 78, pp. 975, http://dx.doi.org/10.1093/jnen/nlz069

Bright F; Werry EL; Dobson-Stone C; Piguet O; Ittner LM; Halliday GM; Hodges JR; Kiernan MC; Loy CT; Kassiou M; Kril JJ, 2019, 'Neuroinflammation in frontotemporal dementia', Nature Reviews Neurology, 15, pp. 540 - 555, http://dx.doi.org/10.1038/s41582-019-0231-z

Nelson PT; Dickson DW; Trojanowski JQ; Jack CR; Boyle PA; Arfanakis K; Rademakers R; Alafuzoff I; Attems J; Brayne C; Coyle-Gilchrist ITS; Fardo DW; Flanagan ME; Halliday G; Hunter S; Jicha GA; Katsumata Y; Kawas CH; Dirk Keene C; Kovacs GG; Kukull WA; Levey AI; Makkinejad N; Montine TJ; Murray ME; Nag S; Seeley WW; Sperling RA; White CL; Schneider JA, 2019, 'Reply: LATE to the PART-y', Brain, 142, pp. 1 - 3, http://dx.doi.org/10.1093/brain/awz226

Ehgoetz Martens KA; Matar E; Hall JM; Phillips J; Szeto JYY; Gouelle A; Grunstein RR; Halliday GM; Lewis SJG, 2019, 'Subtle gait and balance impairments occur in idiopathic rapid eye movement sleep behavior disorder', Movement Disorders, 34, pp. 1374 - 1380, http://dx.doi.org/10.1002/mds.27780

Zhang Q; Vallerga CL; Walker RM; Lin T; Henders AK; Montgomery GW; He J; Fan D; Fowdar J; Kennedy M; Pitcher T; Pearson J; Halliday G; Kwok JB; Hickie I; Lewis S; Anderson T; Silburn PA; Mellick GD; Harris SE; Redmond P; Murray AD; Porteous DJ; Haley CS; Evans KL; McIntosh AM; Yang J; Gratten J; Marioni RE; Wray NR; Deary IJ; McRae AF; Visscher PM, 2019, 'Improved precision of epigenetic clock estimates across tissues and its implication for biological ageing', Genome Medicine, 11, http://dx.doi.org/10.1186/s13073-019-0667-1

Heinzel S; Berg D; Gasser T; Chen H; Yao C; Postuma RB; Adler CH; Bloem B; Chan P; Deuschl G; Dubois B; Goetz CG; Halliday GM; Hardy J; Lang AE; Litvan I; Marek K; Obeso J; Oertel W; Olanow CW; Poewe W; Stern M, 2019, 'Update of the MDS research criteria for prodromal Parkinson's disease', MOVEMENT DISORDERS, 34, pp. 1464 - 1470, http://dx.doi.org/10.1002/mds.27802

Buckland ME; Sy J; Szentmariay I; Kullen A; Lee M; Harding A; Halliday G; Suter CM, 2019, 'Erratum: Correction to: Chronic traumatic encephalopathy in two former Australian National Rugby League players (Acta neuropathologica communications (2019) 7 1 (97))', Acta neuropathologica communications, 7, pp. 122, http://dx.doi.org/10.1186/s40478-019-0772-9

Katzeff JS; Phan K; Purushothuman S; Halliday GM; Kim WS, 2019, 'Cross-examining candidate genes implicated in multiple system atrophy', Acta neuropathologica communications, 7, pp. 117, http://dx.doi.org/10.1186/s40478-019-0769-4

Crook A; McEwen A; Fifita JA; Zhang K; Kwok JB; Halliday G; Blair IP; Rowe DB, 2019, 'The C9orf72 hexanucleotide repeat expansion presents a challenge for testing laboratories and genetic counseling', Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration, 20, pp. 310 - 316, http://dx.doi.org/10.1080/21678421.2019.1588904

Stankovic I; Quinn N; Vignatelli L; Antonini A; Berg D; Coon E; Cortelli P; Fanciulli A; Ferreira JJ; Freeman R; Halliday G; Höglinger GU; Iodice V; Kaufmann H; Klockgether T; Kostic V; Krismer F; Lang A; Levin J; Low P; Mathias C; Meissner WG; Kaufmann LN; Palma JA; Panicker JN; Pellecchia MT; Sakakibara R; Schmahmann J; Scholz SW; Singer W; Stamelou M; Tolosa E; Tsuji S; Seppi K; Poewe W; Wenning GK, 2019, 'A critique of the second consensus criteria for multiple system atrophy', Movement Disorders, 34, pp. 975 - 984, http://dx.doi.org/10.1002/mds.27701

Nelson PT; Dickson DW; Trojanowski JQ; Jack CR; Boyle PA; Arfanakis K; Rademakers R; Alafuzoff I; Attems J; Brayne C; Coyle-Gilchrist ITS; Chui HC; Fardo DW; Flanagan ME; Halliday G; Hokkanen SRK; Hunter S; Jicha GA; Katsumata Y; Kawas CH; Keene CD; Kovacs GG; Kukull WA; Levey AI; Makkinejad N; Montine TJ; Murayama S; Murray ME; Nag S; Rissman RA; Seeley WW; Sperling RA; White CL; Yu L; Schneider JA, 2019, 'Erratum: Limbic-predominant age-related TDP-43 encephalopathy (LATE): consensus working group report. (Brain (2019) 142, (1503–1527) DOI: 10.1093/brain/awz099)', Brain, 142, http://dx.doi.org/10.1093/brain/awz163

Guerreiro R; Escott-Price V; Hernandez DG; Kun-Rodrigues C; Ross OA; Orme T; Neto JL; Carmona S; Dehghani N; Eicher JD; Shepherd C; Parkkinen L; Darwent L; Heckman MG; Scholz SW; Troncoso JC; Pletnikova O; Dawson T; Rosenthal L; Ansorge O; Clarimon J; Lleo A; Morenas-Rodriguez E; Clark L; Honig LS; Marder K; Lemstra A; Rogaeva E; St. George-Hyslop P; Londos E; Zetterberg H; Barber I; Braae A; Brown K; Morgan K; Troakes C; Al-Sarraj S; Lashley T; Holton J; Compta Y; Van Deerlin V; Serrano GE; Beach TG; Lesage S; Galasko D; Masliah E; Santana I; Pastor P; Diez-Fairen M; Aguilar M; Tienari PJ; Myllykangas L; Oinas M; Revesz T; Lees A; Boeve BF; Petersen RC; Ferman TJ; Graff-Radford N; Cairns NJ; Morris JC; Pickering-Brown S; Mann D; Halliday GM; Hardy J; Trojanowski JQ; Dickson DW; Singleton A; Stone DJ; Bras J, 2019, 'Heritability and genetic variance of dementia with Lewy bodies', Neurobiology of Disease, 127, pp. 492 - 501, http://dx.doi.org/10.1016/j.nbd.2019.04.004

Stevens CH; Guthrie NJ; Van Roijen M; Halliday GM; Ooi L, 2019, 'Increased tau phosphorylation in motor neurons from clinically pure sporadic amyotrophic lateral sclerosis patients', Journal of Neuropathology and Experimental Neurology, 78, pp. 605 - 614, http://dx.doi.org/10.1093/jnen/nlz041

Werry EL; Bright FM; Piguet O; Ittner LM; Halliday GM; Hodges JR; Kiernan MC; Loy CT; Kril JJ; Kassiou M, 2019, 'Recent developments in TSPO PET imaging as a biomarker of neuroinflammation in neurodegenerative disorders', International Journal of Molecular Sciences, 20, http://dx.doi.org/10.3390/ijms20133161

Buckland ME; Sy J; Szentmariay I; Kullen A; Lee M; Harding A; Halliday G; Suter CM, 2019, 'Chronic traumatic encephalopathy in two former Australian National Rugby League players', Acta neuropathologica communications, 7, pp. 97, http://dx.doi.org/10.1186/s40478-019-0751-1

Pottier C; Ren Y; Perkerson RB; Baker M; Jenkins GD; van Blitterswijk M; DeJesus-Hernandez M; van Rooij JGJ; Murray ME; Christopher E; McDonnell SK; Fogarty Z; Batzler A; Tian S; Vicente CT; Matchett B; Karydas AM; Hsiung GYR; Seelaar H; Mol MO; Finger EC; Graff C; Öijerstedt L; Neumann M; Heutink P; Synofzik M; Wilke C; Prudlo J; Rizzu P; Simon-Sanchez J; Edbauer D; Roeber S; Diehl-Schmid J; Evers BM; King A; Mesulam MM; Weintraub S; Geula C; Bieniek KF; Petrucelli L; Ahern GL; Reiman EM; Woodruff BK; Caselli RJ; Huey ED; Farlow MR; Grafman J; Mead S; Grinberg LT; Spina S; Grossman M; Irwin DJ; Lee EB; Suh ER; Snowden J; Mann D; Ertekin-Taner N; Uitti RJ; Wszolek ZK; Josephs KA; Parisi JE; Knopman DS; Petersen RC; Hodges JR; Piguet O; Geier EG; Yokoyama JS; Rissman RA; Rogaeva E; Keith J; Zinman L; Tartaglia MC; Cairns NJ; Cruchaga C; Ghetti B; Kofler J; Lopez OL; Beach TG; Arzberger T; Herms J; Honig LS; Vonsattel JP; Halliday GM; Kwok JB; White CL; Gearing M; Glass J; Rollinson S; Pickering-Brown S; Rohrer JD; Trojanowski JQ; Van Deerlin V; Bigio EH; Troakes C; Al-Sarraj S; Asmann Y; Miller BL; Graff-Radford NR; Boeve BF; Seeley WW, 2019, 'Genome-wide analyses as part of the international FTLD-TDP whole-genome sequencing consortium reveals novel disease risk factors and increases support for immune dysfunction in FTLD', Acta Neuropathologica, 137, pp. 879 - 899, http://dx.doi.org/10.1007/s00401-019-01962-9

Nelson PT; Dickson DW; Trojanowski JQ; Jack CR; Boyle PA; Arfanakis K; Rademakers R; Alafuzoff I; Attems J; Brayne C; Coyle-Gilchrist ITS; Chui HC; Fardo DW; Flanagan ME; Halliday G; Hokkanen SRK; Hunter S; Jicha GA; Katsumata Y; Kawas CH; Keene CD; Kovacs GG; Kukull WA; Levey AI; Makkinejad N; Montine TJ; Murayama S; Murray ME; Nag S; Rissman RA; Seeley WW; Sperling RA; White CL; Yu L; Schneider JA, 2019, 'Limbic-predominant age-related TDP-43 encephalopathy (LATE): Consensus working group report', Brain, 142, pp. 1503 - 1527, http://dx.doi.org/10.1093/brain/awz099

Baldo B; Gabery S; Soylu-Kucharz R; Cheong RY; Henningsen JB; Englund E; McLean C; Kirik D; Halliday G; Petersén , 2019, 'SIRT1 is increased in affected brain regions and hypothalamic metabolic pathways are altered in Huntington disease', Neuropathology and Applied Neurobiology, 45, pp. 361 - 379, http://dx.doi.org/10.1111/nan.12514

Warren Olanow C; Savolainen M; Chu Y; Halliday GM; Kordower JH, 2019, 'Temporal evolution of microglia and α-synuclein accumulation following foetal grafting in Parkinson's disease', Brain, 142, pp. 1690 - 1700, http://dx.doi.org/10.1093/brain/awz104

Forrest SL; Crockford DR; Sizemova A; Mccann H; Shepherd CE; Mcgeachie AB; Affleck AJ; Carew-Jones F; Bartley L; Kwok JB; Kim WS; Jary E; Tan RH; Mcginley CV; Piguet O; Hodges JR; Kril JJ; Halliday GM, 2019, 'Coexisting Lewy body disease and clinical parkinsonism in frontotemporal lobar degeneration', Neurology, 92, pp. e2472 - e2482, http://dx.doi.org/10.1212/WNL.0000000000007530

Agarwal S; Ahmed RM; D'Mello M; Foxe D; Kaizik C; Kiernan MC; Halliday GM; Piguet O; Hodges JR, 2019, 'Predictors of survival and progression in behavioural variant frontotemporal dementia', European Journal of Neurology, 26, pp. 774 - 779, http://dx.doi.org/10.1111/ene.13887

Shepherd CE; Alvendia H; Halliday GM, 2019, 'Brain Banking for Research into Neurodegenerative Disorders and Ageing', Neuroscience Bulletin, 35, pp. 283 - 288, http://dx.doi.org/10.1007/s12264-018-0326-3

Back to profile page